165 related articles for article (PubMed ID: 18785279)
1. Active Chinese mistletoe lectin-55 enhances colon cancer surveillance through regulating innate and adaptive immune responses.
Ma YH; Cheng WZ; Gong F; Ma AL; Yu QW; Zhang JY; Hu CY; Chen XH; Zhang DQ
World J Gastroenterol; 2008 Sep; 14(34):5274-81. PubMed ID: 18785279
[TBL] [Abstract][Full Text] [Related]
2. Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses.
Gao Y; Zhang D; Sun B; Fujii H; Kosuna K; Yin Z
Cancer Immunol Immunother; 2006 Oct; 55(10):1258-66. PubMed ID: 16362410
[TBL] [Abstract][Full Text] [Related]
3. The Chinese Herbal Mixture Tien-Hsien Liquid Augments the Anticancer Immunity in Tumor Cell-Vaccinated Mice.
Yang PM; Du JL; Wang GN; Chia JS; Hsu WB; Pu PC; Sun A; Chiang CP; Wang WB
Integr Cancer Ther; 2017 Sep; 16(3):319-328. PubMed ID: 27252074
[TBL] [Abstract][Full Text] [Related]
4. IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas.
Kim PS; Kwilas AR; Xu W; Alter S; Jeng EK; Wong HC; Schlom J; Hodge JW
Oncotarget; 2016 Mar; 7(13):16130-45. PubMed ID: 26910920
[TBL] [Abstract][Full Text] [Related]
5. CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.
Casares N; Arribillaga L; Sarobe P; Dotor J; Lopez-Diaz de Cerio A; Melero I; Prieto J; Borrás-Cuesta F; Lasarte JJ
J Immunol; 2003 Dec; 171(11):5931-9. PubMed ID: 14634104
[TBL] [Abstract][Full Text] [Related]
6. Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection.
Earl PL; Americo JL; Moss B
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747505
[TBL] [Abstract][Full Text] [Related]
7. Concanavalin a injection activates intrahepatic innate immune cells to provoke an antitumor effect in murine liver.
Miyagi T; Takehara T; Tatsumi T; Suzuki T; Jinushi M; Kanazawa Y; Hiramatsu N; Kanto T; Tsuji S; Hori M; Hayashi N
Hepatology; 2004 Nov; 40(5):1190-6. PubMed ID: 15486936
[TBL] [Abstract][Full Text] [Related]
8. Pivotal roles of CD4+ effector T cells in mediating agonistic anti-GITR mAb-induced-immune activation and tumor immunity in CT26 tumors.
Zhou P; L'italien L; Hodges D; Schebye XM
J Immunol; 2007 Dec; 179(11):7365-75. PubMed ID: 18025180
[TBL] [Abstract][Full Text] [Related]
9. A WKYMVm-containing combination elicits potent anti-tumor activity in heterotopic cancer animal model.
Kim SD; Lee HY; Shim JW; Kim HJ; Baek SH; Zabel BA; Bae YS
PLoS One; 2012; 7(1):e30522. PubMed ID: 22295090
[TBL] [Abstract][Full Text] [Related]
10. Polysaccharide from
Park HB; Hwang J; Zhang W; Go S; Kim J; Choi I; You S; Jin JO
Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33302530
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity.
Suzuki E; Kapoor V; Jassar AS; Kaiser LR; Albelda SM
Clin Cancer Res; 2005 Sep; 11(18):6713-21. PubMed ID: 16166452
[TBL] [Abstract][Full Text] [Related]
12. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.
Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM
Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032
[TBL] [Abstract][Full Text] [Related]
13. Peripheral 4-1BB signaling negatively regulates NK cell development through IFN-gamma.
Choi BK; Kim YH; Kim CH; Kim MS; Kim KH; Oh HS; Lee MJ; Lee DK; Vinay DS; Kwon BS
J Immunol; 2010 Aug; 185(3):1404-11. PubMed ID: 20610645
[TBL] [Abstract][Full Text] [Related]
14. Enhanced therapeutic effects against murine colon carcinoma induced by a Colon 26/Ag85A-CD226 tumor cell vaccine.
Li Y; Yang F; Sang L; Zhu J; Han X; Shan F; Li S; Zhai J; Wang D; Lu C; Sun X
Oncol Rep; 2015 Oct; 34(4):1795-804. PubMed ID: 26238268
[TBL] [Abstract][Full Text] [Related]
15. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
[TBL] [Abstract][Full Text] [Related]
16. The antibody-based delivery of interleukin-12 to solid tumors boosts NK and CD8
Puca E; Probst P; Stringhini M; Murer P; Pellegrini G; Cazzamalli S; Hutmacher C; Gouyou B; Wulhfard S; Matasci M; Villa A; Neri D
Int J Cancer; 2020 May; 146(9):2518-2530. PubMed ID: 31374124
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell-induced activation of adaptive and innate antitumor immunity.
van den Broeke LT; Daschbach E; Thomas EK; Andringa G; Berzofsky JA
J Immunol; 2003 Dec; 171(11):5842-52. PubMed ID: 14634094
[TBL] [Abstract][Full Text] [Related]
18. Fuzheng Qingjie Granules Inhibit Growth of Hepatoma Cells via Inducing Mitochondria-Mediated Apoptosis and Enhancing Immune Function.
Chen X; Cao Z; Zhang Y; Li J; Wang S; Du J; Liao L
Integr Cancer Ther; 2017 Sep; 16(3):329-338. PubMed ID: 27335087
[TBL] [Abstract][Full Text] [Related]
19. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells.
Jarnicki AG; Lysaght J; Todryk S; Mills KH
J Immunol; 2006 Jul; 177(2):896-904. PubMed ID: 16818744
[TBL] [Abstract][Full Text] [Related]
20. Exosomes from CIITA-transfected CT26 cells enhance anti- tumor effects.
Fan W; Tian XD; Huang E; Zhang JJ
Asian Pac J Cancer Prev; 2013; 14(2):987-91. PubMed ID: 23621273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
